Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Dimitry Popov

Dimitry Popov

individual
Ecosystem influencer

About

Dimitry Popov is the most clearly verifiable public identity behind this name in the provided research: the CEO of German biotech company MYR GmbH. In HTGF's December 10, 2020 exit announcement, he is quoted as CEO during Gilead Sciences' acquisition of MYR for about EUR 1.15 billion in cash plus milestone payments. Search results also contain other unrelated Dimitry Popovs, but no strong evidence that this person is an investor or fund manager.

Areas of interest

biotechhepatitis therapeuticsvirologyliver disease